Loading clinical trials...
Loading clinical trials...
A Phase I Open-Label Study of Picoplatin in Combination With 5-Fluorouracil and Leucovorin as Initial Therapy in Subjects With Metastatic Colorectal Cancer
Conditions
Interventions
(FOLPI) Picoplatin with 5-FU and Leucovorin
FOLPI
+1 more
Locations
16
Russia
Leningrad Regional Oncology Center, Chemotherapy Department - Phase 2
Kuzmolovsky Village, Vsevolozhsk, Russia
Regional Oncology Center - Phase 2
Astrakhan, Russia
Chelyabinsk Regional Oncology Center - Phase 1
Chelyabinsk, Russia
Regional Oncology Center, Chemotherapy Department - Phase 2
Engel's, Russia
Kazan Oncology Center
Kazan', Russia
Blokhin Russian Oncology Research Center - Phase 1
Moscow, Russia
Start Date
April 1, 2006
Primary Completion Date
December 1, 2009
Completion Date
June 1, 2010
Last Updated
January 21, 2009
NCT04704661
NCT06696768
NCT05489211
NCT06625775
NCT04657068
NCT06445062
Lead Sponsor
Poniard Pharmaceuticals
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions